| Identification | Back Directory | [Name]
Benzo[b]thiophene-2-butanoic acid, 5,6-dimethoxy-α-methyl-γ-oxo-, (αS)- | [CAS]
2218504-06-2 | [Synonyms]
MK2118
Benzo[b]thiophene-2-butanoic acid, 5,6-dimethoxy-α-methyl-γ-oxo-, (αS)- | [Molecular Formula]
C15H16O5S | [MOL File]
2218504-06-2.mol | [Molecular Weight]
308.35 |
| Hazard Information | Back Directory | [Uses]
MK-2118 is a GMP-synthesized STING agonist with the potential to inhibit advanced/metastatic solid tumors or lymphomas.[1]. | [References]
[1] Lyons T W, Thaisrivongs D A, Kuhl N, et al. The First GMP Synthesis of MK-2118, a Small Molecule Agonist for Stimulator of Interferon Genes[J]. Organic Process Research & Development, 2024. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|